Enhanced efficacy and reduced toxicity of multifactorial adjuvants compared with unitary adjuvants as cancer vaccines
Open Access
- 15 March 2008
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 111 (6) , 3116-3125
- https://doi.org/10.1182/blood-2007-09-114371
Abstract
Identification of Toll-like receptors (TLRs) and their ligands, and tumor necrosis factor–tumor necrosis factor receptor (TNF-TNFR) pairs have providKeywords
This publication has 47 references indexed in Scilit:
- Monoclonal Antibodies in the Treatment of Non-Hodgkin???s LymphomaDrugs, 2007
- Immunologic and Clinical Effects of Injecting Mature Peptide-Loaded Dendritic Cells by Intralymphatic and Intranodal Routes in Metastatic Melanoma PatientsClinical Cancer Research, 2006
- Preclinical pharmacokinetics, pharmacodynamics, and activity of a humanized anti‐CD40 antibody (SGN‐40) in rodents and non‐human primatesBritish Journal of Pharmacology, 2006
- CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cellsJournal of Clinical Investigation, 2006
- Pathogenic Role of B Cells in Anti-CD40-Induced Necroinflammatory Liver DiseaseThe American Journal of Pathology, 2006
- Breaking down the barriers to cancer immunotherapyNature Immunology, 2005
- CD154–CD40 interactions drive hepatocyte apoptosis in murine fulminant hepatitis†Hepatology, 2005
- Combined dendritic cell- and CpG oligonucleotide-based immune therapy cures large murine tumors that resist chemotherapyEuropean Journal of Immunology, 2002
- CpG Motifs in Bacterial DNA and Their Immune EffectsAnnual Review of Immunology, 2002
- Innate Immune RecognitionAnnual Review of Immunology, 2002